Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!

FRONTIERS IN IMMUNOLOGY

FRONTIERS MEDIA SA

1. French National Research Agency as part of the Investissements d'Avenir program (LabEx MAbImprove) [ANR-10-LABX-53-01]
2. Region Centre Val-de-Loire (ARD2020 Biomedicament, PRIMine project/APR IR 2019, Novantinh project)
3. French Cystic Fibrosis Foundation VLM [RF20170502036]
4. CEPR
5. Sanofi